- Home
- BCV vs ANIX Comparison
BCV vs ANIX Comparison
Compare BCV & ANIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCV
- ANIX
- Stock Information
- Founded
- BCV 1971
- ANIX 1982
- Country
- BCV United States
- ANIX United States
- Employees
- BCV N/A
- ANIX N/A
- Industry
- BCV Finance/Investors Services
- ANIX Biotechnology: Pharmaceutical Preparations
- Sector
- BCV Finance
- ANIX Health Care
- Exchange
- BCV Nasdaq
- ANIX Nasdaq
- Market Cap
- BCV 115.1M
- ANIX 95.7M
- IPO Year
- BCV N/A
- ANIX 1987
- Fundamental
- Price
- BCV $21.60
- ANIX $3.35
- Analyst Decision
- BCV
- ANIX Strong Buy
- Analyst Count
- BCV 0
- ANIX 3
- Target Price
- BCV N/A
- ANIX $9.00
- AVG Volume (30 Days)
- BCV 26.3K
- ANIX 108.8K
- Earning Date
- BCV 01-01-0001
- ANIX 09-10-2025
- Dividend Yield
- BCV 8.13%
- ANIX N/A
- EPS Growth
- BCV N/A
- ANIX N/A
- EPS
- BCV N/A
- ANIX N/A
- Revenue
- BCV N/A
- ANIX N/A
- Revenue This Year
- BCV N/A
- ANIX N/A
- Revenue Next Year
- BCV N/A
- ANIX N/A
- P/E Ratio
- BCV N/A
- ANIX N/A
- Revenue Growth
- BCV N/A
- ANIX N/A
- 52 Week Low
- BCV $14.09
- ANIX $2.07
- 52 Week High
- BCV $18.11
- ANIX $4.20
- Technical
- Relative Strength Index (RSI)
- BCV 72.99
- ANIX 59.63
- Support Level
- BCV $21.14
- ANIX $2.93
- Resistance Level
- BCV $21.68
- ANIX $3.09
- Average True Range (ATR)
- BCV 0.23
- ANIX 0.16
- MACD
- BCV 0.03
- ANIX 0.06
- Stochastic Oscillator
- BCV 92.23
- ANIX 62.69
About BCV Bancroft Fund Ltd.
Bancroft Fund Ltd is a diversified closed-end management company. It operates as a closed-ended equity mutual fund. The funds' main objective is to provide income and potential for capital appreciation. With the intent to achieve its objective, the company invests in convertible and equity securities. It invests across different industries such as Computer Software and Services, Energy and Utilities, Health Care among others.
About ANIX Anixa Biosciences Inc.
Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.